BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 407684)

  • 1. Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum.
    McHardy N
    Tropenmed Parasitol; 1977 Jun; 28(2):195-201. PubMed ID: 407684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice against Trypanosoma cruzi: the effect of chemical treatment or immune serum on an epimastigote vaccine.
    McHardy N
    Tropenmed Parasitol; 1978 Jun; 29(2):215-22. PubMed ID: 209592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.
    Kierszenbaum F; Howard JG
    J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of specific antibodies in Trypanosoma cruzi infections.
    Krettli AU; Brener Z
    J Immunol; 1976 Mar; 116(3):755-60. PubMed ID: 815433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive protection of mice against infection with Trypanosoma cruzi with plasma: the use of blood- and vector bug-derived trypomastigote challenge.
    McHardy N
    Parasitology; 1980 Jun; 80(3):471-8. PubMed ID: 6771737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
    Basombrio MA; Mora MC; Segura MA
    Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: the fate of bloodstream trypomastigote, amastigote, metacyclic trypomastigote and epimastigote forms in the peritoneal macrophages of immune and non-immune mice in vivo.
    Burger E; Lay WH; Hypolito LV; Fernandes JF
    Acta Trop; 1982 Jun; 39(2):111-22. PubMed ID: 6126093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi.
    Ruiz AM; Esteva M; Cabeza Meckert P; Laguens RP; Segura EL
    Acta Trop; 1985 Dec; 42(4):299-309. PubMed ID: 2868632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant.
    Neal RA; Johnson P
    Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of mice against Trypanosoma cruzi. The effect of size of dose, and route of injection, of immunizing and challenge inocula.
    McHardy H
    Tropenmed Parasitol; 1977 Mar; 28(1):11-6. PubMed ID: 404742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Trypanosoma cruzi to blood clearance induced by acute-phase immune mouse serum.
    Alvarez JM; Marinho CR; Oshima A; Guimaraes L; Menezes H
    J Parasitol; 1992 Dec; 78(6):1074-7. PubMed ID: 1491301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain specific protective immunity against Trypanosoma cruzi.
    Kloetzel JK; Lafaille JJ
    J Parasitol; 1983 Apr; 69(2):267-70. PubMed ID: 6406657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver.
    Scott MT; Moyes L
    Clin Exp Immunol; 1982 Jun; 48(3):754-7. PubMed ID: 6811174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.
    Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV
    Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of the humoral immune response in mice immunized against and inoculated with Trypanosoma cruzi].
    Licón-Trillo A; Pérez-Reyes R
    Rev Latinoam Microbiol; 1994; 36(2):119-25. PubMed ID: 7973179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.